Digital light processing (DLP)‐based bioprinting technology has recently aroused
considerable concerns as a strategy to deliver biomedical materials and/or specific cells to …

Background Breathomics testing has been considered a promising method for detection and
screening for lung cancer. This study aimed to identify breath biomarkers of lung cancer …

Low-dose computer tomographic (LDCT) lung cancer screening reduces lung cancer–
specific and all-cause mortality among high-risk individuals, but implementation has been …

Purpose This article aims to compare the diagnostic performance of 18-fluorodeoxyglucose
([18F] FDG) PET/CT and fibroblast activating protein inhibitor (FAPI) PET/CT in the …

Objective. Cuproptosis is a newly discovered copper‐independent cell death modality, and
limited evidence suggests the critical implications in human cancers. Nonetheless, the …

PURPOSE To investigate the utility of integrating a panel of circulating protein biomarkers in
combination with a risk model on the basis of subject characteristics to identify individuals at …

Lung cancer is a highly heterogeneous cancer and is divided broadly into small and
nonsmall cell lung cancer (SCLC or NSCLC). In all NSCLC patients, it is estimated that 50 …

Computed tomography (CT), an efficient radiological technology, is used to detect lung
cancer in the clinic. Carcinoembryonic antigen (CEA), a common tumor biomarker, is …

Lung cancer is a highly prevalent malignancy worldwide and the primary cause of mortality.
The absence of systematic and standardized diagnostic approaches for identifying potential …

Lung cancer screening by low‐dose computed tomography (LDCT) can improve mortality
rates among high‐risk individuals, especially adenocarcinoma cases with characteristically …